CHZ868 is primarily utilized in the field of antimalarial research. It has shown significant potential in combating drug-resistant strains of malaria, particularly when used in combination therapies. The compound works by targeting the parasite's biology, effectively reducing its ability to survive and proliferate within the host. Researchers are exploring its application in developing new treatment regimens to address the growing issue of resistance to existing antimalarial drugs. Additionally, CHZ868 is being studied for its potential to enhance the efficacy of other antimalarial agents, offering a promising avenue for more effective and sustainable malaria control strategies.